Details for New Drug Application (NDA): 207320
✉ Email this page to a colleague
The generic ingredient in REGADENOSON is regadenoson. There are nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the regadenoson profile page.
Summary for 207320
Tradename: | REGADENOSON |
Applicant: | Gland Pharma Ltd |
Ingredient: | regadenoson |
Patents: | 0 |
Pharmacology for NDA: 207320
Mechanism of Action | Adenosine Receptor Agonists |
Suppliers and Packaging for NDA: 207320
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
REGADENOSON | regadenoson | SOLUTION;INTRAVENOUS | 207320 | ANDA | Gland Pharma Limited | 68083-175 | 68083-175-10 | 10 VIAL in 1 CARTON (68083-175-10) / 5 mL in 1 VIAL (68083-175-01) |
REGADENOSON | regadenoson | SOLUTION;INTRAVENOUS | 207320 | ANDA | Almaject, Inc. | 72611-874 | 72611-874-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (72611-874-10) / 5 mL in 1 VIAL, SINGLE-DOSE (72611-874-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 0.4MG/5ML (0.08MG/ML) | ||||
Approval Date: | Jul 12, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription